 "Cabb begins production of monochloroacetic acid in China")
The German fine chemicals specialist Cabb Group has started production of monochloroacetic acid (MCA) in China, the world’s largest market for this substance. The plant, an investment of Euro 15 million carried out in a joint venture with Chinese company Jining Gold Power, is likely the country’s most modern MCA plant and utilises the latest German hydrogenation technology.
It will produce around 25,000 metric tonnes of monochloroacetic acid a year, initially as flakes only, and later on in liquid state as well. The plant’s central location in Jining, Shandong province, is ideal for supplying local customers as well as multinationals in the greater Beijing and Shanghai regions.
“China is responsible for half of global MCA demand, and this demand is growing at an above-average rate. Now, we are serving this market with local production that sets benchmarks in quality, safety and sustainability,” explained Dr Uwe Brunk, general manager of the acetyls business unit at Cabb.
Peter Vanacker, Cabb Group’s CEO, added, “This investment is a central component in our company’s global growth strategy.”
Cabb is one of the leading and fastest growing international manufacturers of chemical intermediates and finished products, and supplies customers in the agrochemicals and pharmaceuticals industry as well as in the field of specialty chemicals and performance products. Headquartered at Frankfurt, Cabb operates six production sites in Knapsack and Gersthofen (Germany), Pratteln (Switzerland), Kokkola (Finland), Ahmedabad (India) and Jining (China). With around 1,000 employees, Cabb recorded an annual turnover of around Euro 480 million in 2015.
It will produce around 25,000 metric tonnes of monochloroacetic acid a year, initially as flakes only, and later on in liquid state as well. The plant’s central location in Jining, Shandong province, is ideal for supplying local customers as well as multinationals in the greater Beijing and Shanghai regions.
“China is responsible for half of global MCA demand, and this demand is growing at an above-average rate. Now, we are serving this market with local production that sets benchmarks in quality, safety and sustainability,” explained Dr Uwe Brunk, general manager of the acetyls business unit at Cabb.
Peter Vanacker, Cabb Group’s CEO, added, “This investment is a central component in our company’s global growth strategy.”
Cabb is one of the leading and fastest growing international manufacturers of chemical intermediates and finished products, and supplies customers in the agrochemicals and pharmaceuticals industry as well as in the field of specialty chemicals and performance products. Headquartered at Frankfurt, Cabb operates six production sites in Knapsack and Gersthofen (Germany), Pratteln (Switzerland), Kokkola (Finland), Ahmedabad (India) and Jining (China). With around 1,000 employees, Cabb recorded an annual turnover of around Euro 480 million in 2015.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%